Arkolith/Insider Trading/HUMA/Form 4

Niklason Laura E

President, CEO and Director, DirectorHumacyte, Inc. (HUMA) · full profile →Form 4 · filed Sep 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.4M
Net Open-Market Flow
-$2.4M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2024Sell(S)289K$5.23$1.5M3.2M
Sep 9, 2024Sell(S)158K$5.42$855K3.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000184) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML